Evidence map›Paper›PMID 41867557›Full record

ArticleACS omega2026

CustomKinFragLib: Filtering the Kinase-Focused Fragmentation Library.

Paula Linh Kramer, Katharina Buchthal, Dominique Sydow, Katharina Sonja Leo, Andrea Volkamer

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Paula Linh KramerData Driven Drug Design, Center for Bioinformatics, Saarland University, Campus, 66123 Saarbrücken, Germany.ORCID https://orcid.org/0009-0000-0302-8744
Katharina BuchthalData Driven Drug Design, Center for Bioinformatics, Saarland University, Campus, 66123 Saarbrücken, Germany.
Dominique SydowIn Silico Toxicology and Structural Bioinformatics, Institute of Physiology, CharitéUniversitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.ORCID https://orcid.org/0000-0003-4205-8705
Katharina Sonja LeoIn Silico Toxicology and Structural Bioinformatics, Institute of Physiology, CharitéUniversitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
Andrea VolkamerData Driven Drug Design, Center for Bioinformatics, Saarland University, Campus, 66123 Saarbrücken, Germany.ORCID https://orcid.org/0000-0002-3760-580X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein kinases play a crucial role in key regulatory cell processes and are known to be dysregulated in diseases such as cancer and autoimmune disorders. Hence, protein kinases represent a vital drug target class. To meet the challenge of designing novel kinase inhibitors, fragment-based drug discovery (FBDD) has already shown great promise. The kinase-specific fragment library KinFragLib is a data-driven FBDD approach providing a powerful subpocket-specific framework for creating potentially feasible kinase inhibitors through subpocket-guided enumeration and combination of fragments. However, traversing the whole recombination space is computationally infeasible. Here, we introduce CustomKinFragLib, a curation-focused and user-oriented pipeline that builds on the existing KinFragLib framework. Building on the underlying fragmentation methodology, CustomKinFragLib contributes a systematic post hoc reduction and filtering strategy to generate a smaller, more tractable, and synthesis-friendly fragment set. The pipeline integrates literature-derived drug-relevant filters, including assessments of synthetic accessibility, matching to commercially available building blocks, and availability of retrosynthetic pathways. It also considers molecular properties often associated with drug-likeness and removes fragments containing unwanted substructures. Applying these curated filters reduces the original KinFragLib from 9131 to 837 fragments while retaining diverse fragments with drug-like properties and high synthetic tractability, and providing a practical fragment set suitable for downstream design workflows. Our pipeline is easily customizable, allowing for modifications or exclusion of filters based on the user's preferences. The code and data set are available at https://github.com/volkamerlab/KinFragLib.

Identifiers

PMID41867557
PMCPMC13000600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.